TrialJournal of the International AIDS Society2025

Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial.

Tanuja N Gengiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.